# Food and Drug Administration (FDA)

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/food-and-drug-administration-fda
Canonical HTML page: https://gethealthbrief.com/entity/food-and-drug-administration-fda

## Timeline

- **2026-03-08**: Industry Consensus — Scientific American and other major outlets report a definitive decline in global animal experiment volumes.
- **2024-11-10**: Major CRO Pivot — Leading Contract Research Organizations announce multi-million dollar investments in digital twin and OOC labs.
- **2023-06-15**: FDA Guidance on NAMs — The FDA issues initial framework for the submission of data derived from microphysiological systems.
- **2022-12-29**: FDA Modernization Act 2.0 — President Biden signs legislation ending the mandate for animal testing for new drug applications.

## Recent coverage (4 stories)

### Abortions Nearly Double to 20% via Telehealth Pills: New Healthcare Era
2026-06-28 09:16:05 · Sentiment: Neutral · Impact: 7/10 · Sources: 23

U.S. abortions nearly doubled between 2021 and 2025, with medication abortion now 63% of the total. Telehealth delivery has enabled this surge, though misoprostol-only use raises clinical concerns.
Full story: https://gethealthbrief.com/story/abortion-doubling-telehealth-pills

### Wellness Supplement Recalled After Undeclared Viagra Ingredient Discovery
2026-03-13 17:38:37 · Sentiment: Negative · Impact: 6/10 · Sources: 46

A nationwide recall has been issued for a wellness supplement following the discovery of sildenafil, the active ingredient in the prescription drug Viagra. The presence of this undeclared pharmaceutical poses severe health risks, particularly through potentially fatal interactions with common heart medications.
Full story: https://gethealthbrief.com/story/wellness-supplement-recall-viagra-ingredient

### The Battle Over the Airwaves: Reevaluating Direct-to-Consumer Drug Advertising
2026-03-09 11:46:01 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

A renewed public debate over Direct-to-Consumer Advertising (DTCA) is challenging the pharmaceutical industry's marketing status quo in the United States. As healthcare costs escalate, regulators and lawmakers are weighing the educational benefits of patient outreach against the risks of over-prescription and inflated drug prices.
Full story: https://gethealthbrief.com/story/direct-to-consumer-drug-advertising-regulation-debate

### The Post-Animal Era: Regulatory Shifts and Tech Innovation Disrupt Drug R&D
2026-03-08 18:25:48 · Sentiment: Positive · Impact: 7/10 · Sources: 2

The long-standing paradigm of animal experimentation is facing an unprecedented decline as regulatory frameworks and advanced biotechnologies converge. Following the landmark FDA Modernization Act 2.0, the industry is pivoting toward 'New Approach Methodologies' that promise higher human predictive value and lower development costs.
Full story: https://gethealthbrief.com/story/animal-testing-decline-healthcare-regulation

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.